Research Article
Clinicopathologic Significance of CXCL12 and CXCR4 Expressions in Patients with Colorectal Cancer
Table 1
Clinicopathological and treatment characteristics of patients with CRC.
| Variables | Frequency (%) |
| Gender | | Male | 20 (62.5) | Female | 12 (37.5) | Age | | Younger (≤55 years) | 16 (50) | Older (>55 years) | 16 (50) | Clinical stage | | II | 17 (53.2) | III | 10 (31.3) | IV | 5 (15.6) | Location | | Colon | 26 (81.3) | Rectum | 6 (18.8) | Tumour differentiation | | Well | 12 (37.5) | Moderate | 17 (53.2) | Poor | 3 (9.3) | Histological type | | Adenocarcinoma | 29 (90.6) | Adenocarcinoma with mucinous features | 3 (9.3) | Chemotherapy in adjuvant setting | | Oxaliplatin-based | 29 (90.6) | Nonoxaliplatin-based | 2 (6.3) | Missing data | 1 (3.1) | Treatment response | | Complete remission | 17 (53.2) | Partial remission | 0 (0) | Stable disease | 1 (3.1) | Progressive disease | 14 (43.7) |
|
|